Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-104983
Filing Date
2010-11-12
Accepted
2010-11-12 16:31:58
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c08396e10vq.htm 10-Q 576924
2 EXHIBIT 31.1 c08396exv31w1.htm EX-31.1 9808
3 EXHIBIT 31.2 c08396exv31w2.htm EX-31.2 9875
4 EXHIBIT 32.1 c08396exv32w1.htm EX-32.1 3077
5 EXHIBIT 32.2 c08396exv32w2.htm EX-32.2 3109
  Complete submission text file 0000950123-10-104983.txt   604341
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 101187115
SIC: 2834 Pharmaceutical Preparations